Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
alzheimer's disease
biotech
boston blog main
boston top stories
4
×
boulder/denver blog main
boulder/denver top stories
cancer
4
×
detroit blog main
detroit top stories
europe blog main
europe top stories
4
×
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
eli lilly
fda
incyte
merck
moderna
seattle genetics
abbvie
amgen
What
bio
4
×
roundup
buy
debut
moves
week
acquisitions
activity
alliance
approvals
biggest
biogen
black
bristol
build
calls
ceo
changing
clamped
color
companies
company’s
continue
covid
crispr
daniel
days
delays
developing
diamond
diamond’s
drug
dyne’s
economic
fast
fda
gilead
growing
hours
including
Language
unset
4
×
Current search:
cancer
×
bio
×
" boston top stories "
×
unset
×
" europe top stories "
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More